Home / Publications / Highlights of our experience in Pharmaceuticals in...

Highlights of our experience in Pharmaceuticals in the UK

Life Sciences & Healthcare

  • Almirall, S.A. on the transfer of its respiratory franchise for an initial consideration of USD 875m on completion, and up to USD 1.22bn in development, launch and sales-related milestone payments.
  • Takeda Pharmaceutical Company Limited on the EUR 9.6bn (debt-free cash free) acquisition of Swiss drug company, Nycomed A/S. This was one of the most significant deals to occur in the lifesciences sector, with this acquisition increasing Takeda’s footprint and strength in the European market and emerging markets.
  • Perrigo Company on the acquisition of Rosemont Pharmaceuticals Ltd for GBP 180m.
  • US headquartered orphan drug company on the regulation, promotion, compliance and data protection expanding into the EU in the context of the re-acquisition of a pharmaceutical medicinal product.
  • AbbVie on litigation by Chemistree Homecare regarding refusal to supply claims for specific specialist medicines.
  • Chugai Pharma Europe Ltd on the license of exclusive commercialisation rights to Swiss-based Helsinn group's innovative ghrelin receptor agonist, anamorelin, for the three major European pharma markets.
  • A global pharmaceutical company on a compliance systems review across six major Western European markets against current anti-corruption requirements in each jurisdiction, in conjunction with detailed national pharmaceutical regulatory requirements applicable to interactions with health professionals and procurement authorities.
  • A global pharmaceutical company on the risks caused by changes to its corporate structure and contracting arrangements to open the client up to the jurisdiction of the Bribery Act 2010 and other extraterritorial anti-corruption legislation.
  • Futura Medical on the licensing of the manufacture and distribution of its CSD500 product to multiple pharmaceutical and healthcare groups.
  • A multinational leading pharmaceutical company on the launch of a potential blockbuster drug, involving advising on, and coordinating, freedom to operate and validity issues across 18 countries.

Please download the print version below.

Various bottles of chemicals
Brochures
Pharmaceuticals
Download
PDF 166.1 kB